Nontuberculous Mycobacterial Infections Associated With Left Ventricular Assist Devices in 3 Patients |
| |
Authors: | Manavotam Singh Mrinalini Krishnan Maria Elena Ruiz Farooq H. Sheikh |
| |
Affiliation: | 1. Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC ; 2. Section of Infectious Diseases, Department of Medicine, MedStar Washington Hospital Center, Washington, DC |
| |
Abstract: | Durable left ventricular assist devices (LVADs) provide circulatory support in patients with end-stage heart failure; however, complications include infection of the driveline exit site. Nontuberculous mycobacterial infections are rare in patients with LVADs, but they should be considered in those who have undergone device exchanges and have bacterial infections with driveline exit-site discharge but no fever or leukocytosis.We reviewed the charts of patients who had an LVAD implanted at our institution from January 2009 through December 2019, to identify those with a device-related nontuberculous mycobacterial infection. Collected data included patient demographics, premorbid conditions, infection type, previous device complications, treatment, and outcomes. We identified infections in 3 patients (mean age, 41 yr): Mycobacterium abscessus in 2 and M. chimaera in 1. All had a HeartMate II device and had undergone device exchanges for pump thrombosis or for driveline fault or infections. All presented with driveline exit-site discharge without fever or leukocytosis. The mean time between initial device implantation and diagnosis of a nontuberculous mycobacterial infection was 55 months. All 3 patients were treated with antibiotics and underwent localized surgical débridement; one underwent an additional device exchange. The M. abscessus infections disseminated, and both patients died; the patient with M. chimaera infection continued to take suppressive antibiotics.Nontuberculous mycobacterial infections are associated with high morbidity and mortality rates, warranting prompt diagnosis and treatment. |
| |
Keywords: | Anti-bacterial agents/therapeutic use debridement fatal outcome heart-assist devices/adverse effects/microbiology mycobacterium infections nontuberculous/drug therapy/etiology/microbiology prosthesis-related infections/diagnosis/drug therapy/etiology/microbiology treatment outcome |
|
|